Ingevity Corp - SCHEDULE 13G/A Filing

This filing is an amendment to a previous Schedule 13G filing for Ingevity Corp, reported by The Vanguard Group. The amendment, dated March 27, 2026, indicates no change in beneficial ownership, with 0 shares owned and 0% ownership. The filing states that Vanguard, including its investment companies and managed accounts, has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities. It clarifies that no single other person has more than a 5% interest in the reported securities. A significant note explains that as of January 12, 2026, The Vanguard Group, Inc. underwent an internal realignment, leading to a disaggregated reporting of beneficial ownership by certain subsidiaries and business divisions, in accordance with SEC Release No. 34-39538. Consequently, The Vanguard Group, Inc. no longer claims beneficial ownership over securities held by these entities, which continue to pursue the same investment strategies.